| 发明名称 |
α,α-disubstituted arylalkylamine derivative, pharmaceutical composition and use of α,α-disubstituted arylalkylamine |
| 摘要 |
The present invention features calcilytic compounds. "Calcilytic compounds" refer to compounds able to inhibit calcium receptor activity. Also described are the use of calcilytic compounds to inhibit calcium receptor activity and/or achieve a beneficial effect in a patient; and techniques which can be used to obtain additional calcilytic compounds. |
| 申请公布号 |
PL191027(B1) |
申请公布日期 |
2006.03.31 |
| 申请号 |
PL19970329314 |
申请日期 |
1997.04.04 |
| 申请人 |
NPS PHARMACEUTICALS, INC.;SMITHKLINE BEECHAM PLC;SMITHKLINE BEECHAM |
发明人 |
VAN WAGENEN BRADFORD C.;DEL MAR ERIC G.;SHEEHAN DEREK;BARMORE ROBERT M.;KEENAN RICHARD M.;KOTECHA NIKESH R.;THOMPSON MERVYN;CALLAHAN JAMES F. |
| 分类号 |
C07C217/30;G01N33/50;A61K31/13;A61K31/135;A61K31/137;A61K31/18;A61K31/277;A61K31/36;A61K31/38;A61K31/395;A61K31/404;A61P19/00;A61P19/08;A61P19/10;C07C217/14;C07C217/28;C07C217/34;C07C217/38;C07C217/60;C07C217/62;C07C217/64;C07C255/46;C07C255/54;C07C311/29;C07C323/25;C07C323/62;C07D209/42;C07D213/65;C07D317/58;C07D317/64;C07D333/70;G01N33/15 |
主分类号 |
C07C217/30 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
